Also trades as: PANACEABIO.NS (NSE) · $vol 2M

₹351.65 ($3.65)

-6.25 (-1.75%)

BSE · Healthcare · Biotechnology · Tech Score Sell · Power 38 · ₹21.9B mcap · 15M float · 0.206% daily turnover

Revenue

$6.4B +14.4% ▲

5Y CAGR: +0.7%

Gross Profit

$1.5B -59.5% ▼

5Y CAGR: -18.8%

Operating Income

-$377M +37.9% ▲

Net Income

-$54M +35.8% ▲

EPS (Diluted)

$-0.88 +35.8% ▲

EBITDA

-$47M -115.2% ▼

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$6.6B	$4.6B	$5.5B	$5.6B	$6.4B
YoY Growth	+6.7%	-30.7%	+20.8%	+1.3%	+14.4%
Cost of Revenue	$3.2B	$2.8B	$2.7B	$2.0B	$4.9B
Gross Profit	$3.4B	$1.8B	$447M	$3.6B	$1.5B
Gross Margin	51.8%	39.0%	8.1%	64.3%	22.7%
R&D Expenses	$105M	$328M	$369M	$428M	$0
SG&A Expenses	$758M	$1.5B	$580M	$2.1B	$1.8B
Operating Expenses	$3.9B	$1.8B	$585M	$4.2B	$1.8B
Operating Income	-$518M	-$1.1B	-$138M	-$607M	-$377M
Operating Margin	-7.9%	-23.1%	-2.5%	-10.9%	-5.9%
Interest Expense	$1.8B	$44M	$36M	$39M	$60M
Income Before Tax	$14.5B	$128M	$15M	-$80M	-$74M
Tax Expense	$3.7B	$466M	$30M	$8M	-$2M
Net Income	$10.8B	-$332M	-$12M	-$84M	-$54M
Net Margin	163.6%	-7.3%	-0.2%	-1.5%	-0.8%
EPS (Diluted)	$176.05	$-5.43	$-0.19	$-1.37	$-0.88
EBITDA	$16.7B	$564M	$415M	$307M	-$47M
Shares Outstanding	61M	61M	61M	61M	61M

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$1.2B	$1.5B	$1.6B	$1.3B	$1.7B	$1.4B	$1.7B	$1.7B
Cost of Revenue	$880M	$432M	$626M	$521M	$772M	$589M	$1.2B	$1.3B
Gross Profit	$278M	$1.0B	$1.0B	$804M	$895M	$822M	$483M	$357M
Gross Margin	24.0%	70.7%	61.7%	60.7%	53.7%	58.2%	29.2%	21.4%
R&D Expenses	$0	$0	$0	$428M	$0	$0	$0	$0
SG&A Expenses	$505M	$0	$0	$582M	$0	$0	$450M	$410M
Operating Expenses	$505M	$1.1B	$1.0B	$1.2B	$990M	$1.1B	$450M	$410M
Operating Income	-$227M	-$17M	-$10M	-$353M	-$96M	-$261M	$33M	-$53M
Operating Margin	-19.6%	-1.1%	-0.6%	-26.6%	-5.7%	-18.5%	2.0%	-3.2%
Interest Expense	$9M	$10M	$10M	$10M	$9M	$21M	$18M	$12M
Income Before Tax	-$170M	$48M	$44M	-$400K	$66M	-$192M	$65M	-$12M
Tax Expense	-$12M	$500K	-$600K	$20M	$26M	-$52M	$26M	-$2M
Net Income	-$158M	$48M	$45M	-$19M	$40M	-$139M	$40M	$5M
Net Margin	-13.7%	3.3%	2.8%	-1.4%	2.4%	-9.9%	2.4%	0.3%
EPS (Diluted)	$-2.59	$0.77	$0.74	$-0.31	$0.66	$-2.27	$0.65	$0.08
EBITDA	-$74M	$144M	$144M	$94M	$158M	-$87M	$117M	$26M
Shares Outstanding	61M	62M	61M	61M	61M	61M	61M	65M

PANACEABIO.BO BSE